[Current concepts on apoptotic signalling pathways: new targets for anticancer strategies]

Evelyne Ségal-Bendirdjian1, Josette Hillion, Chafké Ahmed Belmokhtar

  • 1Inserm U496, Centre G. Hayem, Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris. esegal@juputer.chu-stlouis.fr

Bulletin Du Cancer
|March 1, 2003
PubMed

Insights

Apoptosis, programmed cell death, is vital for development and homeostasis. Understanding its molecular pathways aids in developing new anticancer strategies and optimizing existing drug therapies.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Context:

  • Apoptosis is a fundamental physiological process crucial for organismal development and maintaining cellular balance.
  • Dysregulation of apoptosis is implicated in the development of cancer and resistance to therapeutic drugs.
  • Multiple, independent signaling pathways meticulously control the process of apoptosis.

Purpose:

  • To elucidate the molecular mechanisms underlying apoptosis.
  • To provide a foundation for developing rational anticancer strategies.
  • To explore novel therapeutic approaches targeting apoptotic pathways.

Summary:

  • Apoptosis, or programmed cell death, is a tightly regulated process essential for development and homeostasis.
  • Defects in apoptotic pathways can lead to cancer development and drug resistance.
  • Understanding these molecular events is key to designing effective anticancer treatments.

Impact:

  • Facilitates the development of novel therapeutic molecules that target specific apoptotic signaling pathways.
  • Enables the improved utilization of existing drugs by identifying synergistic combinations targeting distinct pathways.
  • Advances the field of oncology by providing a molecular basis for innovative cancer treatment strategies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.